CytoMed Therapeutics Limited (GDTC)
$1.00-2.91%Close
BUYRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $12M
- Avg volume
- 61.8K
- Beta
- 0.05
- P/E (TTM)
- -3.14
- Short % float
- 0.16%
- Days to cover
- 1.0
- SI change
- -81.2%
- 1W
- +9.89%
- 1M
- +1.01%
- 3M
- -11.50%
- YTD
- -28.06%
- vs SPY 1W
- +11.08%
- vs SPY 1M
- -2.31%
- vs SPY 3M
- -13.90%
- vs SPY YTD
- -39.81%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…